Stroke leads to brain damage with subsequent slow and incomplete recovery of lost brain functions. Enriched housing of stroke-injured rats provides multi-modal sensorimotor stimulation, which improves recovery, although the specific mechanisms involved have not been identified. In rats housed in an enriched environment for two weeks after permanent middle cerebral artery occlusion, we found increased sigma-1 receptor expression in peri-infarct areas. Treatment of rats subjected to permanent or transient middle cerebral artery occlusion with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride, an agonist of the sigma-1 receptor, starting two days after injury, enhanced the recovery of lost sensorimotor function without decreasing infarct size. The sigma-1 receptor was found in the galactocerebroside enriched membrane microdomains of reactive astrocytes and in neurons. Sigma-1 receptor activation increased the levels of the synaptic protein neurabin and neurexin in membrane rafts in the peri-infarct area, while sigma-1 receptor silencing prevented sigma-1 receptor-mediated neurite outgrowth in primary cortical neuronal cultures. In astrocytic cultures, oxygen and glucose deprivation induced sigma-1 receptor expression and actin dependent membrane raft formation, the latter blocked by sigma-1 receptor small interfering RNA silencing and pharmacological inhibition. We conclude that sigma-1 receptor activation stimulates recovery after stroke by enhancing cellular transport of biomolecules required for brain repair, thereby stimulating brain plasticity. Pharmacological targeting of the sigma-1 receptor provides new opportunities for stroke treatment beyond the therapeutic window of neuroprotection.
Introduction
Stroke causes tissue infarction and malfunction of neural networks, leaving stroke patients with permanent cognitive, sensory or motor deficits. Restorative processes in the surviving brain tissue after a stroke lead to a limited recovery of neurological function, typically within 3 months following stroke (Duncan et al., 2000) . There is presently no approved drug-based therapy that stimulates recovery of neurological functions in stroke patients (Endres et al., 2008) . However, methods such as transcranial magnetic or electrical brain stimulation, which are thought to stimulate use-dependent brain plasticity, enhance recovery if combined with rehabilitative training (Hummel et al., 2005; Koganemaru et al., 2010) . Multiple cellular mechanisms appear to contribute to the recovery process, and are differentially activated in time and space. They encompass wound healing with gliosis and inflammation, and neuronal plasticity, typically with axonal outgrowth, dendritic arborizations and synaptogenesis (Wieloch and Nikolich, 2006) . While brain plasticity after injury has mainly been related to functional restoration of neuronal networks (Murphy and Corbett, 2009) , the role of astrocytes has not fully been recognized. Astrocytes are important for synaptic homeostasis and neurotransmission (Nedergaard and Dirnagl, 2005) . They contribute to scar formation that encapsulates the infarcted tissue and limits inflammation (Bush et al., 1999) . Astrocytes also promote neuronal regeneration through delivery of trophic factors and cellular constituents such as lipids. Essentially all lipids, and particularly cholesterol, are synthesized in the brain and mainly in astrocytes (Vance et al., 2005) . Cholesterol together with galactocerebrosides are essential constituents of lipid microdomains, known as lipid or membrane rafts (Viola and Gupta, 2007) , which form cellular vehicles for trafficking of lipids and proteins and platforms for cell signalling molecules. The sigma-1 receptor (Sig-1R) is a membrane spanning cholesterol binding protein (Palmer et al., 2007) implicated in intracellular trafficking (Hayashi and Su, 2001) , signalling and neurotransmission (Dun et al., 2007) . The Sig-1R was recently identified as a novel molecular chaperone at the mitochondria-associated endoplasmic membrane, sensing endoplasmic reticulum Ca 2+ concentration and regulating endoplasmic reticulum-mitochondrial inter-organellar Ca 2+ signalling and cell survival (Hayashi and Su, 2007; Meunier and Hayashi, 2010) . Housing rodents in an enriched environment after brain injury provides a multi-modal sensorimotor stimulation to the brain that enhances recovery of neurological functions following experimental stroke (Ohlsson and Johansson, 1995) . In this experimental paradigm we found upregulation of approximately 110 gene transcripts, among others the Sig-1R gene. To determine the relevance of the Sig-1R for functional recovery after stroke we analysed its involvement in the repair and plasticity processes in brain cells. We found (i) that the Sig-1R is upregulated in surviving brain tissue in the peri-infarct region of animals with good neurological recovery, particularly in reactive astrocytes; (ii) that Sig-1R is located in membrane rafts of astrocytes and neurons and is essential for membrane raft trafficking and neurite outgrowth and (iii) that a potent and selective Sig-1R agonist, [1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) -piperazine dihydrochloride, (SA4503)] (Matsuno et al., 1997) , presently investigated in a stroke clinical phase II trial, enhances recovery of function in rat models of stroke with a 2-day post-infarct treatment initiation window.
Materials and methods

Animal surgery and treatments
All animal experiments were carried out according to the National Institutes of Health guidelines for the care and use of laboratory animals, and approved by the Ethical Committee at Lund University. We used two methods of experimental stroke and two methods for analysis of neurological functions according to the recommendations (STAIRS, 1999) .
Permanent middle cerebral artery occlusion
Permanent middle cerebral artery occlusion (MCAO) was performed on male spontaneously hypertensive rats (Harlan, Harlow, UK; 12-18 weeks, 350-400 g) essentially as described earlier (Ohlsson and Johansson, 1995) . The rats were anaesthetized [50 mg/kg pentobarbital sodium (i.p.) or Hypnorm/Dormicum (1:1 + 2 parts sterile water, dose: 2.7 ml/kg]. A small craniotomy was made above the zygomatic arch and the right middle cerebral artery was ligated with a 10-0 monofilament nylon thread distal to the origin of the striatal branches. Surgery was performed over a period of 20-40 min. After surgery, all animals were transferred to their home cages.
Transient middle cerebral artery occlusion
Transient MCAO was induced in male Wistar rats by transient MCAO for 90 or 120 min with a nylon thread introduced into the internal carotid artery and advanced to the middle cerebral artery bifurcation under anaesthesia (3% isoflurane in O 2 with spontaneous ventilation). Body temperature was maintained at 37 AE 1 C for 6 h after occlusion (Memezawa et al., 1992; Ruscher et al., 2009) .
Housing in an enriched environment
The method has been described previously (Johansson and Ohlsson, 1996; Rickhag et al., 2008) . Briefly, the rats were either housed in standard laboratory cages (standard housing) or in large cages with multilevel platforms connected with beams and chains, tubes and ladders. The environment, i.e. positions of the different moveable parts in the cage were changed every 3-4 days. Two experimental series were performed-one for assessment of Sig-1R protein level by western blotting and one for the complementary DNA array analysis. Generally, animals were subjected to permanent MCAO and after 2 days in their home cage randomly selected for housing in an enriched environment or standard housing for 12 days. All animals showed severe neurological deficit (circling behaviour and contralateral forelimb dysfunction) prior to differential housing. For Sig-1R protein determination there were five animals in either housing condition, and for the array study there were 10 animals in standard and enriched housing, respectively. After 12 days in the enriched or standard environment, the animals were lightly anaesthetized with isoflurane, the brains were removed, frozen in isopentane chilled to À 50 C and stored in a freezer at À80 C. Brain tissue for analysis from the ipsilateral hemisphere was dissected in a glove box at À 14 C.
Treatment with SA4503
In one treatment series animals were subjected to permanent MCAO and randomly assigned to either the vehicle treated or SA4503 (0.3 mg/kg i.p.) treated groups. Two days later the animals were tested on the rotating pole and those with a severe deficit (score 0, 1 or 2) were included in the study. The vehicle treated (n = 20) and the SA4503 treated animals (n = 22) were again tested after 14 and 28 days of treatment and again at 14 days after termination of the treatment. In another experimental series rats were subjected to transient MCAO and treated daily, starting 2 days after transient MCAO, with vehicle (n = 13), and SA4503 0.3 mg/kg (n = 15) and 1.0 mg/kg i.p. (n = 11), respectively. These animals were tested on the foot-fault test at 2, 14 and 28 days after MCAO. Rats not showing a deficit at 2 days were excluded from the study. To study membrane raft fractions in the peri-infarct area, rats were tested on the rotating pole and those with a severe deficit (score 0, 1 or 2) were injected with vehicle (n = 6; i.p.), and SA4503 0.5 mg/kg (n = 6; i.p.) for 5 days.
Neuroprotection by SA4503 was studied in male Wistar rats subjected to transient MCAO (90 min) and treated with either vehicle (saline, i.p., n = 10) or SA4503 (1 mg/kg, i.p., n = 5) 5 min prior and 2 h after transient MCAO. For immunohistochemistry and immunofluorescence, brains were analysed from a separate series of rats subjected to 90 min transient MCAO (n = 5) or sham surgery (n = 5) both groups with 7 days recovery.
Behavioural analysis
The rotating pole test measures coordination and integration of movement (Johansson and Ohlsson, 1996; Rickhag et al., 2008) . Rats traverse an elevated wooden pole (elevation 700 mm, diameter 40 mm, length 1500 mm) rotating at a speed of 10 rpm. The home cage was placed at the opposite end of the rotating pole to stimulate the animal to traverse the pole. Animals were trained prior to induction of the permanent MCAO until they successfully traversed the pole (usually 6-10 trials). Following permanent MCAO, each animal was tested twice at the predetermined time of recovery (Johansson and Ohlsson, 1996) . Animal behaviour was recorded by a video camera and a score (0-6) was subsequently assigned to each performance by an observer blinded to the treatment assignment: 0, falls off the pole immediately upon entry onto the pole; 1, enters the pole but is unable to traverse the pole and remains sitting across the pole; 2, falls off the pole while crossing; 3, crossing the pole while continuously slipping with the forelimbs and jumping with the hind limbs, and the hind limbs do not contribute to forward movement; 4, crossing the pole while continuously slipping with the limbs; 5, crossing with few (3-6) slips; 6, crossing with no foot slips. There was no time limit for crossing the pole. A score of 5-6 is considered a normal performance. The foot-fault test is a sensitive indicator of forelimb sensorimotor function (Hernandez and Schallert, 1988) . The test was performed at Days 7, 6, 5 and 1 prior to and at Days 2, 14 and 28 after injury. The number of missteps was recorded and analysed.
2,3,5-Triphenyltetrazolium chloride-staining and brain infarction measurements
Forty-eight hours after reperfusion, rats were lightly anaesthetized with isoflurane and brains were removed and placed in cold saline for 20 min. Seven coronal slices (2 mm thick) were stained with 2,3,5-triphenyltetrazolium chloride (TTC, 1% solution in saline) at 37 C for 30 min. The same procedure was performed for shamoperated animals. Brain slices were photographed using a CCD camera and the damaged (unstained) area was defined as infarcted tissue. Infarct volumes were corrected for oedema using an image analysis program (ImageProPlus) (Swanson et al., 1990) .
Assessment of neurite outgrowth
Primary neuronal cultures were prepared (Ruscher et al., 2002) and plated at a density of 0.8 Â 10 4 cells/well in a 96-well plate in neurobasal medium containing B27 and allowed to attach at 37 C in 5% CO 2 for 3 h.
After treatment with different concentrations of SA4503, neurite outgrowth was assessed. Neurons were labelled by indirect immunofluorescence using a primary antibody to the neuronal form of tubulin and an Alexa Fluor 488 conjugated secondary antibody. Neurite outgrowth was quantified using an image analysis algorithm (Neurite Outgrowth BioApplication, ArrayScan HCS System, Cellomics Inc.).
Astrocytic cell culture
Astroglial cell cultures were prepared according to a modified method described previously (Ruscher et al., 2002) . In brief, meninges from cortices of newborn Wistar rats were removed and the tissue was mechanically dissected and digested in trypsin/EDTA solution (0.05% Trypsin, 0.02% EDTA) at 37 C for 15 min. After digestion, the tissue was washed twice in phosphate buffered saline followed by a mechanical dissociation in Dulbecco's minimal essential medium. The dissociated cells were seeded in 75 cm 2 flasks (cells from two brains/flask).
Cells were grown in culture medium (Dulbecco's minimal essential medium, 10% foetal calf serum, 1% penicillin/streptomycin, 2 mM L-glutamine, 0.1% glucose). After 10 days, cultures were shaken for 1 h (250 rpm) in order to remove microglial cells and astrocytes were resown in subcultures into appropriate culture dishes.
Spine morphology
Primary cultures of hippocampal neurons from GFP-actin expressing mice (density 20 cells/mm 2 ) (Gisselsson et al., 2005) were plated on poly-L-lysine coated cover glasses and grown in neurobasal A medium (supplemented with B27, 0.5 mM L-glutamine, 100 U penicillin/ streptromycin/ml, 20 mM HEPES, 10 ng/ml fibroblast growth factor 2 and 5 mM cytosine arabinoside, Invitrogen). After maturation (7-10 days in vitro), cells were mounted in a temperature controlled culture chamber (Warner Instruments, Hamden, CT, USA) perfused by a MS-Reglo pump (Ismatec SA, Glattbrugg, Switzerland, perfusion rate of 260 ml/min). Oxygen tension in the cell culture medium was monitored continuously using a Clark electrode (Consort Z921, Tumhout, Belgium). Changes in the morphology of dendritic protrusions were assessed by a time-lapse imaging system utilizing a cooled digital camera (F-view) mounted on an Olympus IX-81 fluorescence microscope and recorded by the Soft Imaging System SIS software (AnalySIS Olympus, Germany) (Gisselsson et al., 2005) . GFP filters and natural density filters (Chroma Technology, Rockingham, USA) were used to minimize phototoxicity and bleaching.
Time lapse recordings
Immediately after combined hypoxia/aglycaemia, cav1-GFP transfected astrocytes (Supplementary material) were transferred from the hypoxia/aglycaemia chamber into a temperature controlled (37 C) gas tight chamber flushed with 5% CO 2 mounted on a stage of a confocal microscopy system (LSM510 Zeiss, Germany). Consecutive pictures were captured every 20 s for 1 h using a minimum laser intensity (1%), Argon/2-laser and a 3 mm pinhole diameter covering the thickness of the cells. For control experiments, astrocytes kept under normoxic conditions in control-solution were transferred immediately from the incubator to the stage chamber.
Combined hypoxia and aglycaemia 0.8 mM) in an hypoxic atmosphere (1% oxygen). Hypoxia was generated in a dedicated humidified, gas tight incubator (Electrotek, Shipley, UK), flushed with gas of the following composition: 5% CO 2 , 85% N 2 and 10% H 2 . During hypoxia/aglycaemia (10 min), oxygen tensions in the media were below 1 mmHg (continuous measurement by a Clark electrode, Consort Z921 4 0.8 mM, glucose 4.5 g/l) after washing with phosphate buffered saline, and cells were incubated in a normoxic atmosphere containing 5% CO 2 . Immediately after hypoxia/aglycaemia, solutions were replaced by fresh culture medium. At different time points, cells were processed for further analyses.
In vitro treatment protocols
piperazine dihydrochloride (SA4503, AGY Therapeutics Inc., San Francisco, CA, USA) and 1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine (BD1063, Tocris, UK) were dissolved in sterile ultrapure water and used in a final concentration of 10 mM. Latrunculin (EMD Biosciences, Calbiochem, CA, USA) and nocodazole (Sigma Aldrich, Deisenhofen, Germany) were dissolved in dimethyl sulphoxide. For actin depolymerization immediately after hypoxia/aglycaemia or control stimulation, cells were incubated with 1 : 100 dilutions in a final concentration of 5 mM latrunculin. Disruption of microtubules was achieved by addition of nocodazole (final concentration 100 mM) immediately after hypoxia/aglycaemia or control, respectively. After 4 h, drug-containing culture medium was replaced by fresh culture medium. Twenty hours later, cultures from the same preparation were processed for immunocytochemical analysis.
Detergent resistant membrane fractions
Cells or brain tissue were homogenized in ice-cold homogenization buffer [10 mM TRIS (pH 7.4), 5 mM EDTA, 320 mM sucrose, 1 mg/ml of the protease inhibitors aprotinin, leupeptin and pepstatin, 2 mM phenylmethylsulphonyl fluoride, 250 mM benzamidine, 2 mM sodium orthovanadate, 1 mM sodium fluoride]. After centrifugation at 800 g for 10 min, the ensuing supernatant was spun at 9200 g for 15 min. After further centrifugation of the resuspended pellet (P2) at 10200 g for 15 min the P2 0 pellet was resuspended in extraction buffer (10 mM Tris, 150 mM NaCl, 5 mM EDTA, 1 mM phenylmethylsulphonyl fluoride, 10 mg/ml aprotinin, 2% sucrose, 0.5% Triton X-100) and sonicated (Ultrasonic Homogenizer 4710, ColeParmer, Chicago, IL, USA) for 3 s. Extraction of detergent resistant membrane was ensured by shaking at 4 C for 30 min. The suspension was overlaid with a continuous sucrose gradient (5-40%) in a Quick-Seal tube (12 Â 32 mm, Beckman Coulter, CA, USA) and centrifuged at 50 000 rpm for 4 h at 4 C (Rotor TLA 100.2, Beckman Coulter). Twelve fractions were collected from the top and equal volumes of the fractions were separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis and analysed by immunoblotting.
Sigma-1 receptor small interfering RNA
Freshly dissociated primary cortical neurons (4.8 Â 10 6 cells) were resuspended in nucleofection buffer. Sig-1R specific (GGCUUGAGCU CACCACCUA) or scrambled (UAGCGACUAAACACAUCAAUU) small interfering RNA oligonucleotides were added and the resuspended neurons were electroporated using the Nucleofector Õ program G-13
(Nucleofector technology, Amaxa). In order to measure neurite outgrowth induced by SA4503 in the context of the Sig-1R knockdown, the compound was added to give a final concentration of 3 mM and the cells were incubated for 3 days in presence of the compound. Specific Sig-1R small interfering RNA was delivered into primary astrocytes using Lipofectamine TM RNAiMax (Invitrogen) using the reverse transfection protocol, according to the manufacturer's instructions. For assessment of the degree of receptor knockdown, cells were lysed in 100 ml lysis buffer, sonicated and run on a 4-20% Tris glycine gel.
Western blotting
Samples were diluted in sodium dodecyl sulphate sample buffer [final concentrations: 62.5 mM Tris-HCl (pH 6.8), 2% sodium dodecyl sulphate, 10% glycerol, 50 mM dithiothreitol, 0.1% bromophenol blue] and the mixture was boiled for 5 min. Twenty microlitres of mixture was separated on a 15% sodium dodecyl sulphate polyacrylamide gel. Blocking was performed onto polyvinyldifluoride membranes using blocking buffer (20 mM Tris, 136 mM NaCl, pH 7.6, 0.1% Tween-20, 5% non-fat dry milk), and detected using primary polyclonal antibodies against the Sig-1R (1 : 2000, AGY, CA, USA), caveolin-3 (1 : 2000, BD Biosciences Pharmingen, Europe), neurabin (1 : 500, BD Biosciences Pharmingen) and neurexin I (1 : 500, BD Biosciences Pharmingen).
After overnight incubation at 4 C, signals were obtained by binding of respective secondary horseradish peroxidase-conjugated antibodies (1 : 1500, New England Biolabs, Sweden), and visualized by exposing the membrane to a CCD camera (Raytest, Germany) using a chemiluminescence kit (Amersham Biosciences, UK). Membranes were stripped in respective buffer [final concentrations: 62.5 mM Tris (pH 6.7), 100 mM b-mercaptoethanol, 2% sodium dodecyl sulphate] at 70 C for 30 min and reprobed for -tubulin (clone B-5-1-2, Sigma, Germany, and diluted 1 : 10000). Immunoblotting was performed as described above using an anti-mouse horseradish peroxidaseconjugated secondary antibody (Cell Signalling, MA, USA, and diluted 1 : 1500). After densitometric analysis, expression levels were calculated as percentage of -tubulin expression assumed to be stable in all treatment groups.
Immunohistochemistry
Cells were washed gently with phosphate buffered saline (without Ca 2+ /Mg 2+ ), fixed with 4% paraformaldehyde in phosphate buffered saline at room temperature for 10 min and rinsed three times with phosphate buffered saline. Brain sections (thickness 30 mm) from paraformaldehyde perfused animals were washed three times in phosphate buffered saline. For detection of proteins, the following antibodies were used: rabbit polyclonal anti-Sig-1R (1 : 200), mouse monoclonal anti-galactocerebroside (1 : 200, Millipore, MA, USA), monoclonal anti-myc (1 : 1000, Invitrogen, UK), goat polyclonal anti-cav3 (1 : 1000, BD Biosciences, NJ, USA), and monoclonal directly Cy3 conjugated anti-GFAP (1 : 5000, Sigma-Aldrich, MO, USA). After overnight incubation at 4 C, cells or free floating sections were incubated with appropriate secondary antibodies. Fluorescent signals were visualized using a confocal microscopy system (LSM510 Zeiss, Germany). Omission of primary antibodies always served as a negative control. For bright-field immunohistochemistry, a standard peroxidase-based method using 3,3 0 -diaminobenzidine was applied. Briefly, free-floating sections (thickness 30 mm) were rinsed in phosphate buffered saline followed by incubation in 3% H 2 O 2 and 10% methanol to remove endogenous peroxidase activity. After preincubation with 5% normal swine serum using 0.25% Triton X-100 in phosphate buffered saline for 1 h, sections were incubated with Sig-1R antibody (1 : 400). The second day, sections were incubated with biotinylated swine anti-rabbit secondary antibody (1 : 200, Dako Cytomation, Glostrup, Denmark) for 85 min followed by incubation with avidin-biotin-complex (Vector Laboratories, Burlingame, USA) for 1 h. By using 3,3 0 -diaminobenzidine as a chromogen, the reaction was visualized and further enhanced by NiCl 2 . After rinsing, sections were mounted, air-dried overnight, dehydrated, immersed in xylene and finally cover-slipped using Pertex (Histolab Products AB, Gothenburg, Sweden). Phenotypic characterization of cells was performed using dual-label or triple-label immunofluorescence using the primary antibodies NeuN, GST-, Ox-42, NG2, nestin and doublecortin, as specified in Supplementary Table 2 . The sections were incubated with primary antibodies (overnight in phosphate buffered saline containing 5% normal donkey serum with 0.25% Triton X-100). On the second day, sections were rinsed and incubated with respective Cy3-conjugated donkey anti-mouse (1 : 200, Jackson ImmunoResearch Laboratories, USA) and Cy2-conjugated anti-rabbit secondary antibody (1 : 200, Jackson ImmunoResearch Laboratories). Sections were then mounted and cover-slipped with polyvinyl alcohol-DABCO Õ (Sigma-Aldrich AB, Sweden) to preserve the fluorophores. Analyses were performed with a LSM 510 confocal microscope (Zeiss, Germany).
Statistics
In cell culture experiments, unless otherwise stated, experiments were conducted in triplicate. Data are presented as means AE SD. In the experimental stroke studies, the rotating pole test and infarct size measurements were analysed with the Kruskal-Wallis and MannWhitney non-parametric tests, the foot-fault test data were analysed with two way ANOVA and post hoc Bonferroni correction.
Results
Improved functional recovery after stroke correlates with increased sigma-1 receptor levels
Rats were subjected to experimental stroke by MCAO, and housed in enriched cages for 12 days starting 2 days after stroke. Their neurological functions dramatically recovered compared with rats housed in standard cages (Fig. 1A ), in accordance with earlier publications (Ohlsson and Johansson, 1995; Rickhag et al., 2008 (Keyvani et al., 2004 , Carmichael et al., 2005 . Ten genes were related to lipid metabolism (steroid and myelin synthesis) and membrane rafts, these included the Sig-1R. We analysed the levels of Sig-1R in the brain tissue from animals in the experimental series displayed in Fig. 1A . Using an antibody against the N-terminal sequence of the Sig-1R we found increased levels of Sig-1R protein in the crude membrane fraction (100 000 g pellet) from the cortex and striatum (including adjacent white matter) of the injured hemisphere from rats housed in an enriched environment compared with tissue from rats housed in standard conditions ( Fig. 1B and C) .
Sigma-1 receptor activation enhances recovery of sensorimotor function following experimental stroke
To assess whether Sig-1R activation enhances functional recovery of rats subjected to experimental stroke, the effect of treatment with the highly specific and selective Sig-1R agonist SA4503 was investigated. In a first experimental series, spontaneous hypertensive rats were subjected to permanent MCAO. Starting 2 days after permanent MCAO, disabled rats that were not able to cross a rotating pole, were subcutaneously (s.c.) injected with either 0.3 mg/kg SA4503 (n = 22) or saline (n = 20), with continued treatment for 28 days with daily injections. At Day 2 after MCAO all animals showed a severe neurological deficit (0, 1 or 2) on the rotating pole test with no difference in deficit between SA4503-treated and vehicle-treated groups ( Fig. 2A) . At 2 weeks of recovery, the SA4503-treated group showed significantly better improvement (P 5 0.01 in Mann-Whitney test) in motor function compared with the vehicle group, and the performance was further enhanced after 4 weeks of recovery ( Fig. 2A) (P 5 0.01 in Mann-Whitney test). When vehicle and SA4503 treatment was discontinued for 2 weeks, the recovery enhancing effect of SA4503 persisted (P 5 0.01 in MannWhitney test). All vehicle-treated animals had severe difficulties crossing the rotating pole, while SA4503-treated animals traversed the pole with few or no slips. Importantly, the size of the infarct measured in NeuN immunostained sections, was not significantly different between the saline and SA4503-treated groups (Fig. 2B) .
In an additional experimental group, animals were injected with either vehicle (n = 10) or 1 mg/kg i.p. (n = 5) of SA4503 at 5 min prior to and at 2 h after transient MCAO. This treatment did not decrease infarct size (Supplementary Fig. 1 ). In a second experimental series, an experimental model mimicking stroke with reperfusion, 90 min of transient occlusion of the middle cerebral artery (transient MCAO) was applied and the rats tested for motor function using the foot-fault test prior to (pre), and 2 days, 2 and 4 weeks after transient MCAO (Fig. 2C) . Before induction of transient MCAO the animals made a small number of faults during the test. As an indication of severe functional impairment, all animals included in the study had severe deficit at 2 days after transient MCAO. Subsequently, the vehicle-treated animals retained difficulty in performing the foot-fault test, resulting in increased numbers of foot faults at 2 and 4 weeks of recovery compared with sham operated animals. In the SA4503-treated animals (0.3 and 1 mg/kg daily s.c.), motor function improved, and the number of foot faults decreased and was less compared with the vehicle-treated rats and not significantly different from sham operated rats by 4 weeks of treatment. In summary, we demonstrate that treatment with a Sig-1R agonist starting 2 days after injury improves sensorimotor function in models of experimental stroke without affecting infarct size. Importantly, when treatment was discontinued after 4 weeks the performance of SA4503-treated animals remained significantly better than the vehicle-treated group after an additional 2-week observation period.
The sigma-1 receptor is mainly upregulated in reactive astrocytes
To assess the cellular basis for the improved neurological function by the Sig-1R activation, we analysed its cellular distribution. The Sig-1R immunoreactivity was increased from 2 days of recovery onwards in cells conspicuously localized in the peri-infarct area and the corpus callosum and around the lateral ventricle (Fig. 3A) . The Sig-1R staining was localized in some but not all reactive astrocytes (GFAP + /nestin + cells) (Fig. 3B ). In the intact peri-infarct tissue Sig-1R staining was present but weak in neurons (NeuN  + ) and not found in doublecortin positive cells (DCX + ), oligodendrocytes (GST-+ ), NG2 + cells and microglia (OX42 + ). When paraffin embedded sections were processed for antigen retrieval, we found immunoreactivity in the cytosol and dendrites of cortical neurons ( Supplementary Fig. 2 ). In astrocytes, the Sig-1R staining was located in the cytosol and frequently in small membrane protrusions (Fig. 3C ). Caveolin-3 (cav3) immunoreactivity was present in some Sig-1R + /GFAP + cells in the peri-infarct tissue ( Fig. 3D and E), and in these cells galactocerebrosides are partially colocalized with the Sig-1R, suggesting that this receptor is attached to Sigma-1 receptor and stroke recovery membrane raft-containing structures (Fig. 3F) . Hence, the Sig-1R is mainly upregulated in reactive astrocytes after MCAO suggesting an important role of these cells for functional recovery after experimental stroke.
Sigma-1 receptors are essential for membrane raft trafficking in astrocytes activated by hypoxia/aglycaemia
To investigate the significance of the Sig-1R overexpression in astrocytes and its colocalization with membrane rafts, we exposed cultured astrocytes to a sublethal episode (10 min) of hypoxia/ aglycaemia, and studied events during the subsequent recovery period. In detergent-resistant membrane fractions prepared from astrocytes harvested at 24 h after hypoxia/aglycaemia stimulation, cav3 was found in those fractions with expected specific densities of membrane rafts, but was not detected in membrane rafts in astrocytes after control stimulation (normoxic/normoglycaemic atmosphere) (Fig. 4A ). Caveolin-1 showed a similar localization pattern after hypoxia/aglycaemia stimulation as cav3 (data not shown). Also in astrocytes, galactocerebrosides and cholesterol, the principal components of membrane rafts, were present in structures around the nucleus in unstimulated cells. These structures appeared to disperse into the cytoplasm as clusters upon hypoxia/aglycaemia stimulation ( Supplementary Fig. 2 ). To study the dynamics of membrane raft formation after hypoxia/aglycaemia stimulation, cav1-GFP (Pelkmans et al., 2001 ) transfected astrocytes were investigated by live cell imaging. Single, small cav1-GFP containing membrane rafts were seen in the cytosol of control cells (Fig. 4B, Supplementary Video 1) . Within minutes after hypoxia/aglycaemia activation, an increased number of membrane rafts were generated in the cytoplasm, and individual cav1-GFP membrane rafts increased in size and/or aggregated into larger domains (Fig. 4C) . Also, in several cells an increased trafficking of cav-1-GFP membrane rafts in 10 mm increments was (n = 11) of SA4503 was initiated after two days of recovery after MCAO and continued daily for 28 days. Values are means AE SD. Improvement of neurological function was enhanced in the 1 mg/kg SA4503 treated group compared with the saline treated group after 2 weeks and 4 weeks of treatment (P 5 0.05 after 2 weeks and P 5 0.01 after 4 weeks between vehicle and 1.0 mg/kg SA4503 treated group, two way ANOVA followed by the Bonferroni correction). Video 2) , along what appeared to be linear tracks suggesting an association with the cytoskeleton. Since the Sig-1R binds to ankyrin-spectrin complexes (Hayashi and Su, 2001) , and actin stimulates clustering of membrane raft proteins (Chichili and Rodgers, 2007) , we investigated the importance of actin polymers for membrane raft formation in astrocytes.
seen (Supplementary
In hypoxia/aglycaemia-stimulated astrocytes, the actin depolymerizing agent latrunculin (5 mM for 4 h after hypoxia/aglycaemia) prevented membrane raft formation as indicated by the loss of cav3 in the detergent resistant fractions (Fig. 5A) . Likewise, the perinuclear localization of galactocerebrosides in unstimulated astrocytes, and their formation in the cytoplasm upon hypoxia/ aglycaemia activation was abolished by latrunculin treatment (Supplementary Fig. 3 ). The disruption of actin fibres by latrunculin was confirmed in cultured astrocytes transfected with enhanced-GFP-actin (data not shown). The enhanced membrane raft formation was insensitive to microtubule disruption by nocodazole (100 mM, data not shown). Actin polymerizationdepolymerization is regulated by the small Rho-GTPase Rac1 (Hall, 2005) . Transfection of wild-type Rac-1 (Rac-wt) or the constitutively active Rac-K61 construct into astrocytes did not influence membrane raft formation in control and hypoxia/aglycaemia activated cells (data not shown). In contrast, transfection with the dominant negative construct Rac-N17 markedly impaired membrane raft formation and translocation to the cytosol (Fig. 5B) . The Rac constructs contained a c-myc tag, and ample c-myc immunoreactivity (green) was seen in both transfected control and hypoxia/aglycaemia cultures (Fig. 5C) . In hypoxia/aglycaemia exposed Rac-wt transfected astrocytes, galactocerebrosides colocalized with Rac1 (Fig. 5C) . Hence, astrocytic membrane raft formation and trafficking following hypoxia/aglycaemia is dependent on the presence of polymerized actin and Rac1.
We next assessed the importance of the Sig-1R for membrane raft dynamics in astrocytes. The Sig-1R levels increased by $30% in hypoxia/aglycaemia stimulated astrocytes (Fig. 6A) , and the receptor protein accumulated in the detergent resistant membrane fractions indicative of localization in membrane rafts (Fig. 6B) . Also, in stimulated astrocytes, Sig-1R immunoreactivity increased in cytosolic globular structures and colocalized with galactocerebrosides (Fig. 6C) . To assess the functional significance of the Sig-1R for membrane raft formation after hypoxia/aglycaemia, Sig-1R expression was silenced by transfection of specific Sig-1R small interfering RNA. Forty-eight hours after transfection, a decreased level of Sig-1R was detected by immunoblotting ( Supplementary Fig. 4) . In control cultures, transfection with scrambled small interfering RNA did not affect the overall structure of galactocerebroside positive membrane rafts compared with the non-transfected cells that displayed a prominent presence of membrane rafts in the cytosol (Fig. 6D) . In contrast, in Sig-1R small interfering RNA transfected cells, the membrane rafts were smaller and were located around the nucleus. After hypoxia/aglycaemia in Sig-1R small interfering RNA transfected cells, membrane rafts did not increase in size and did not accumulate in the cytosol but remained localized around the nucleus. In these cells, some galactocerebroside staining accumulated both along the plasma membrane and as stripe-like structures in the cytoplasm. To investigate whether a Sig-1R antagonist would affect membrane raft dynamics after hypoxia/aglycaemia we treated astrocytes with BD1063 (10 mM) for 24 h following hypoxia/aglycaemia. Immunoblotting of the detergent-resistant membrane fractions after hypoxia/aglycaemia showed Sig-1R in membrane rafts and a complete absence of the protein in these fractions when astrocytes were treated with BD1063 (Fig. 6E) . Also, in hypoxia/ aglycaemia stimulated astrocytes, the increase in cytosolic membrane raft formation (galactocerebroside immunoreactivity) was abolished by BD1063 (Fig. 6F) . In these cells, galactocerebroside staining appeared as stripe-like structures (Fig. 6G) . Thus Sig-1Rs are located in membrane rafts and are instrumental in membrane raft formation and trafficking in hypoxia/ aglycaemia stimulated astrocytes. These processes can be modulated by Sig-1R ligands, notably by a small molecule Sig-1R antagonist.
Sigma-1 receptor activation induces neuronal plasticity
To assess the expression of proteins associated with neurite outgrowth and spinogenesis and their integration in membrane rafts, we performed an additional series of experiments and the peri-infarct tissue of rats treated with either 0.5 mg/kg SA4503 (n = 6) or vehicle (saline; n = 6) for five consecutive days starting at Day 2 following transient MCAO. In vehicle-treated animals, neurabin, a protein associated with the formation of neurites (Orioli et al., 2006) , and neurexin I, involved in presynaptic differentiation (Dean et al., 2003) , were mainly found in the high density membrane fraction (Fig. 7) . In contrast, treatment with SA4503 resulted in increased levels of both proteins and both proteins preferentially accumulated in the low density fractions, which contain membrane rafts. Indeed, in cultured cells we found that Sig-1R activation induces changes in spine morphology and stimulates neurite outgrowth. In hippocampal neurons from actin-GFP expressing mice, grown for 7-10 days in vitro in the presence of 3 mM SA4503, the spine heads were wider ( Fig. 8A ) and the width increased by $25% (Fig. 8B ). ; n = 6) and SA4503 (0.5 mg/kg, i.p.; n = 6) treated animals. Data are presented as mean AE SE, *P 5 0.05, **P 5 0.01 versus the protein level detected in the same fraction after vehicle treatment (two way ANOVA followed by the Bonferroni correction).
Treatment of primary neuronal cultures (2 days in vitro) with the Sig-1R agonist SA4503 stimulates neurite outgrowth (Fig. 8C ) in a dose-dependent fashion (1-10 mM SA4503) (Fig. 8D) , and after 2 days of treatment mean neurite length increased by 42-fold (P 5 0.01 in Tukey's test) (Fig. 8E) .
Silencing with Sig-1R small interfering RNA significantly decreased the levels of Sig-1R protein compared with a scrambled small interfering RNA sequence ( Supplementary Fig. 4 ) and markedly depressed neurite outgrowth in both vehicle and SA4503 stimulated neurons, compared with scrambled small interfering RNA transfected cells (Fig. 8F ). These results demonstrate the neuronal plasticity promoting effects of SA4503 both in cultured cells and in the peri-infarct area of rats subjected to experimental stroke.
Discussion
Stroke treatment based on neuroprotective strategies has proven elusive, and alternative therapeutic efforts now focus on stimulating the recovery of the surviving brain tissue (Wieloch and Nikolich, 2006; Gonzenbach and Schwab, 2008) . Compensatory plasticity in this brain region is a fundamental mechanism of the functional recovery after stroke. We hypothesized that differential gene expression analysis of brain tissue from rats subjected to stroke and housed in either a standard or an enriched environment during recovery, could provide leads to mechanisms that promote repair and functional recovery after stroke. Using this experimental approach we found an upregulation of genes associated with tissue remodelling, such as cell signalling, extracellular matrix, exo-endocytosis, protein trafficking and metabolism. Out of the 110 genes upregulated at least 2-fold, more than half were related to brain plasticity, including genes coding for proteins involved in synaptic function, lipid transport and synthesis. We also found for the first time a significant upregulation of the Sig-1R gene in brains of rats housed in enriched conditions after injury. This is of particular interest since the Sig-1R modulates synaptic transmission, binds to membrane rafts and is involved in cellular trafficking of proteins and lipids, processes important for brain plasticity Su, 2001, 2003; Martina et al., 2007) . We therefore explored the relevance of the Sig-1R in mechanisms of recovery after experimental stroke. Our data demonstrate that treating animals with an agonist to the Sig-1R, starting 2 days after MCAO, could mimic the recovery-promoting effect of enriched environment and enhance recovery of function. Indeed, treatment with the Sig-1R agonist SA4503 starting at 2 days after MCAO and continued for several weeks significantly improves sensorimotor function when assessed after 14 days or 28 days of treatment. This improved functional recovery is not due to the neuroprotective actions demonstrated by some Sig-1R agonists (Bhardwaj et al., 1998; Goyagi et al., 2003; Katnik et al., 2006) , since by 2 days after experimental stroke, when treatment started, expansion of the infarct has essentially subsided in this model (Chandra et al., 1999) . We show here that treatment with the Sig-1R agonist starting immediately upon reperfusion or at 2 days after MCAO, does not decrease infarct size. Importantly, the restorative effect of the Sig-1R agonist is not transient. In fact, we observed that the significant improvement of neurological function following MCAO was sustained when treatment with SA4503 was discontinued for 2 weeks. This finding clearly demonstrates that Sig-1R agonist treatment increases rather than hastens the extent of recovery following MCAO. Our studies were performed in young Wistar rats (age 12-18 weeks) but should be repeated in aged rats, known to have diminished capacity for functional recovery (Buga et al., 2008) . Several pharmacological studies, where the treatment was initiated at a time when cell death has essentially subsided, showed improved functional recovery after experimental stroke. For example, carbamylated erythropoietin (Villa et al., 2007) and granulocyte-colony stimulating factor (Schneider et al., 2006) enhance functional recovery after MCAO and are currently evaluated in clinical trials for stroke recovery. Amphetamine has been thoroughly investigated for its recovery promoting properties in animals and man (Barbay and Nudo, 2009 ). Studies performed so far suggest that multiple mechanisms contribute to different aspects of functional recovery (Wieloch and Nikolich, 2006) , and therefore several mechanisms must be targeted by pharmacological or physical means to provide optimal functional restoration after stroke (Wieloch and Nikolich, 2006) . In this perspective, enriched housing enhances recovery by several mechanisms in a coordinated manner (Johansson, 2004) . In analogy, at the cellular level, the Sig-1R acts in both neurons and glia cells on multiple processes, including cell signalling and trafficking.
Glia cells are important for recovery after stroke (Nedergaard and Dirnagl, 2005; Sofroniew, 2005; Li et al., 2008) . The marked increase of Sig-1R expression in astrocytes after experimental stroke strongly suggests that the recovery promoting action of the Sig-1R involves astrocytes in the peri-infarct area, including the corpus callosum adjacent to the infarct. The finding that the Sig-1R is colocalized with markers of membrane rafts in reactive astrocytes strongly indicates that the action of Sig-1R involves the enhanced cellular trafficking of lipid microdomains (Hayashi and Su, 2003) . Membrane raft formation depends on cytoskeletal rearrangements pertinent for intracellular transport (Delacour and Jacob, 2006; Potokar et al., 2007) . Our observations show that activated Rac1 is involved in the regulation of membrane raft association to the actin cytoskeleton and thereby in cytoplasmic transport of the membrane microdomains. Studies in NG108 cells have earlier shown that the Sig-1R is localized in lipid microdomains in the endoplasmic reticulum (Hayashi and Su, 2003) , regulating lipid transport from the cytosol to the plasma membrane. Here we report a marked stimulation of membrane raft formation in the cytosol in cultured astroglial cells exposed to sublethal hypoxia/aglycaemia, mimicking conditions present in tissue surviving an experimental stroke. The enhanced membrane raft trafficking is highly dependent on the presence and the activation of the Sig-1R. Our results clearly show that in hypoxia/aglycaemia exposed astrocytes, pretreatment with Sig-1R small interfering RNA or application of the Sig-1R antagonist BD1063 immediately after hypoxia/aglycaemia, abolishes both the formation of and trafficking of galactocerebroside-containing membrane raft microdomains. This strongly supports a role of the Sig-1R in lipid compartmentalization and export in astrocytes. Since astrocytes are the main cholesterol synthesizing cells in the brain (Vance et al., 2005) , Sig-1R may be involved in the cholesterol transport from the endoplasmic reticulum (Hayashi and Su, 2003) for export to regenerating neurons. Interestingly, Sig-1R colocalizes with mitochondria and the endoplasmic reticulum (Hayashi and Su, 2007) , where steroids and particularly neurosteroids, potential endogenous ligands to the Sig-1R, are synthesized. Hence, Sig-1R in the present context could facilitate transport of cholesterol and sterols from membrane rafts at the mitochondria-endoplasmic reticulum junction.
The importance of neuronal plasticity for recovery of brain function after injury is well established (Nudo, 2007) , and both long and short range axonal sprouting have been demonstrated (Chen et al., 2002; Lee et al., 2004; Dancause et al., 2005) . In neurons, membrane rafts provide structural signalling platforms for receptor subunit trafficking (Hering et al., 2003) and for signalling downstream of guidance receptors in neurites (Guirland et al., 2004) . Here we show that neurabin, a protein involved in neurite outgrowth (Orioli et al., 2006) and neurexin I, a protein that is associated with the formation of synapses (Dean et al., 2003) , are upregulated after MCAO and integrated in detergent resistant membrane raft fractions in the peri-infarct area upon treatment with SA4503. The data suggest that Sig-1R activation promotes neurite outgrowth and spine remodelling, a prerequisite for the formation of new synapses (Murphy and Corbett, 2009) , and indicate reorganization of neuronal circuits in the peri-infarct area. The involvement of Sig-1R in neuronal plasticity is further substantiated by our findings that Sig-1R activation markedly stimulated neurite outgrowth in primary cortical neurons, dramatically attenuated by Sig-1R small interfering RNA. Also, we found that SA4503 induced spine remodelling, similar to that caused by constitutively active Rac1 transfected into neurons and implicated in spine plasticity (Majewska et al., 2000; Tashiro and Yuste, 2004) . This is in agreement with the observed increase in dendritic branching and spine density in the brains of rats housed in an enriched environment after experimental stroke (Johansson and Belichenko, 2002) . Also, a recent 2-photon live cell imaging study showed that dendritic spines in the peri-infarct area collapse during MCAO and partially reappear in the recovery phase (Brown et al., 2008) , a process that could involve Sig-1R activation.
We conclude that the Sig-1R activation contributes to the formation of a milieu permissive for neuronal regeneration in the brain of stroke-injured rats. This is accomplished by stimulation of intracellular trafficking of cellular constituents in neurons and astrocytes enhancing synaptogenesis and wound healing at the infarct border. The use of compounds stimulating macromolecular trafficking in general and Sig-1R agonists in particular could significantly expand the current narrow therapeutic window of stroke treatment, and also be applicable in treating other neurodegenerative diseases.
